FDA approves first drug to treat tardive dyskinesia
The U.S. Food and Drug Administration today approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
Archive for the ‘Food Safety News’ category
FDA approves two hepatitis C drugs for pediatric patients
The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.
FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
The U.S. Food and Drug Administration today allowed marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests for 10 diseases or conditions. These are the first direct-to-consumer (DTC) tests authorized by the FDA that provide information on an individual’s genetic predisposition to certain medical diseases or conditions, which may help to make decisions […]
In Association with Lakeside Foods, Inc., ALDI Voluntarily Recalls Season’s Choice Frozen Sweet Peas
In cooperation with Lakeside Foods, Inc., and out of an abundance of caution, ALDI has voluntarily recalled Season’s Choice Frozen Sweet Peas due to possible Listeria monocytogenes contamination. Upon notification from the supplier, ALDI immediately removed the affected product from its stores. Read The Complete Story!
Lakeside Foods, Inc. Recalls Season’s Choice Frozen Sweet Peas Because of Possible Health
Lakeside Foods, Inc. of Manitowoc, WI is voluntarily recalling 1,920 packages of 16 ounce Season’s Choice Brand Frozen Peas packed for Aldi, Inc. distributed in 7 states because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, […]
Allergen Alert: Wegmans Food Markets, Inc. Issues Allergen Alert on Undeclared Peanuts in Wegmans Original Killer Brownies with Pecans, Sold Individually or Pre-packaged by the pound in Bakery in New York State Stores Only
Wegmans Food Markets, Inc. has initiated a voluntary recall of Wegmans Original Killer Brownies with Pecans, because the product may contain peanuts, not declared on the label. People who have an allergy to peanuts run the risk of serious or life-threatening allergic reaction if they consume this product. Read The Complete Story!
Allergen Alert: Wegmans Food Markets, Inc. Issues Allergen Alert on Undeclared Peanuts in Wegmans Original Killer Brownies with Pecans, Sold Individually or Pre-packaged by the pound in Bakery in New York State Stores Only
Wegmans Food Markets, Inc. has initiated a voluntary recall of Wegmans Original Killer Brownies with Pecans, because the product may contain peanuts, not declared on the label. People who have an allergy to peanuts run the risk of serious or life-threatening allergic reaction if they consume this product. Read The Complete Story!
Conagra Brands Recalls Hunt’s Chili Kits Due To Potential Presence Of Salmonella In Spice Packet
Conagra Brands, Inc., announced today it is voluntarily recalling a limited amount of Hunt’s Chili Kits due to the potential presence of Salmonella in the chili seasoning packet contained in the kit. The chili seasoning used in the packet originated from a supplier who informed the company of the potential presence of Salmonella in a […]
Conagra Brands Recalls Hunt’s Chili Kits Due To Potential Presence Of Salmonella In Spice Packet
Conagra Brands, Inc., announced today it is voluntarily recalling a limited amount of Hunt’s Chili Kits due to the potential presence of Salmonella in the chili seasoning packet contained in the kit. The chili seasoning used in the packet originated from a supplier who informed the company of the potential presence of Salmonella in a […]
FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr
The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in […]
FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr
The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in […]
Lifestyle Evolution Voluntarily Recalls One Shift of NuGo Slim Crunchy Peanut Butter
The recall is only for Lot B16119A. No other products are affected. Lifestyle Evolution is voluntarily recalling one shift of NuGo Slim Crunchy Peanut Butter nutrition bars. In isolated cases, a product with milk allergen was incorrectly packaged into Slim Crunchy Peanut Butter wrappers and cartons. The NuGo Slim Crunchy Peanut Butter wrapper does not […]
FDA approves new drug to treat multiple sclerosis
On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by the FDA for PPMS. Ocrevus is an intravenous infusion given by a health care professional.
FDA approves new eczema drug Dupixent
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Dupixent can be used with or without topical corticosteroids.
FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers
The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
Pro Sports Club Recalls Yogurt Peanut Crunch Bar Because of Possible Health Risk
Pro Sports Club of Bellevue, WA is recalling 36.957 Yogurt Peanut Crunch bars because it may be contaminated with Escherichia coli H7 bacteria (E.Coli O157:H7) E Coli O157:H7 causes a diarrheal illness often with bloody stools. Although most healthy adults can recover completely within a week, some people can develop a form of kidney failure […]
FDA approves first treatment for rare form of skin cancer
The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer.
Riviana Foods Inc. Voluntarily Recalls Certain Manufacturing Date And UPC Number Of Ronzoni® Thin Spaghetti Due To Possible Undeclared Egg Allergen
Houston, Texas (March 20, 2017) – Riviana Foods Inc. is voluntarily recalling 610 cases of certain coded Ronzoni® Thin Spaghetti cartons that may contain an egg fettuccine product. The affected Ronzoni Thin Spaghetti cartons do not declare the allergen “egg”, which is an ingredient in the egg fettuccine product. People who have an allergy or […]
FDA approves drug to treat Parkinson’s disease
The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes. An “off” episode is a time when a patient’s medications are not working well, causing an increase in Parkinson’s symptoms, such as tremor and difficulty walking.